Literature DB >> 22525373

Synaptic and nonsynaptic mitochondria demonstrate a different degree of calcium-induced mitochondrial dysfunction.

Chontida Yarana1, Jantira Sanit, Nipon Chattipakorn, Siriporn Chattipakorn.   

Abstract

AIMS: Since variety in response to Ca(2+)-induced mitochondrial dysfunction in different neuronal mitochondrial populations is associated with the pathogenesis of several neurological diseases, we investigated the effects of Ca(2+) overload on synaptic (SM) and nonsynaptic mitochondrial (NM) dysfunction and probed the effects of cyclosporin A (CsA), 4'-chlorodiazepam (CDP) and Ru360 on relieving mitochondrial damage. MAIN
METHODS: SM and NM mitochondria were isolated from rats' brains (n=5/group) and treated with various concentrations (5, 10, 100, and 200 μM) of Ca(2+), with and without CsA (mPTP blocker), CDP (PBR/TSPO blocker) and Ru360 (MCU blocker) pretreatments. Mitochondrial function was determined by mitochondrial swelling, ROS production and mitochondrial membrane potential changes (ΔΨm). KEY
FINDINGS: At 200-μM Ca(2+), SM presented mitochondrial swelling to a greater extent than NM. At 100 and 200-μM Ca(2+), the ROS production of SM was higher than that of NM and ΔΨm dissipation of SM was also larger. CsA, CDP and Ru360 could reduce ROS production of SM and NM with exposure to 200-μM Ca(2+). However, only Ru360 could completely inhibit ROS generation in both SM and NM, whereas CsA and CDP could only partially reduce the ROS level in SM. Moreover, CsA and CDP pretreatments were not able to restore ΔΨm. However, Ru360 pretreatment could protect ΔΨm dissipation in both SM and NM, with complete protection observed only in NM. SIGNIFICANCE: Our findings suggested that mitochondrial calcium uniporter is a possible major pathway for calcium uptake in both mitochondrial populations. However, SM might have additional pathways involved in the calcium uptake.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525373     DOI: 10.1016/j.lfs.2012.04.004

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Brain cortex mitochondrial bioenergetics in synaptosomes and non-synaptic mitochondria during aging.

Authors:  Silvia Lores-Arnaiz; Paulina Lombardi; Analía G Karadayian; Federico Orgambide; Daniela Cicerchia; Juanita Bustamante
Journal:  Neurochem Res       Date:  2016-01-28       Impact factor: 3.996

2.  Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons.

Authors:  Susanne P Pallo; Gail V W Johnson
Journal:  Neurosci Lett       Date:  2015-04-15       Impact factor: 3.046

3.  iTRAQ-Based Quantitative Proteomics Suggests Synaptic Mitochondrial Dysfunction in the Hippocampus of Rats Susceptible to Chronic Mild Stress.

Authors:  Hong Xie; Haojun Huang; Min Tang; Yan Wu; Rongzhong Huang; Zhao Liu; Mi Zhou; Wei Liao; Jian Zhou
Journal:  Neurochem Res       Date:  2018-10-22       Impact factor: 3.996

4.  Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

Authors:  Hui-Fang Liu; Philip Wing-Lok Ho; Gideon Chi-Ting Leung; Colin Siu-Chi Lam; Shirley Yin-Yu Pang; Lingfei Li; Michelle Hiu-Wai Kung; David Boyer Ramsden; Shu-Leong Ho
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

5.  Quantitative proteomics of synaptic and nonsynaptic mitochondria: insights for synaptic mitochondrial vulnerability.

Authors:  Kelly L Stauch; Phillip R Purnell; Howard S Fox
Journal:  J Proteome Res       Date:  2014-04-22       Impact factor: 4.466

Review 6.  Transfer RNA and human disease.

Authors:  Jamie A Abbott; Christopher S Francklyn; Susan M Robey-Bond
Journal:  Front Genet       Date:  2014-06-03       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.